Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic LeukemiaKathryn G. Roberts, Timothy P. Hughes, John Easton et al.|New England Journal of Medicine|2014Cited by 1.4k
Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemiaSarah K. Tasian, Stephan A. Grupp|Blood|2016Cited by 163
Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALLChristian Hurtz, Sarah K. Tasian|Journal of Clinical Investigation|2020Cited by 58
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapiesBranko Cuglievan, Naveen Pemmaraju, Jeremy Connors et al.|Leukemia|2023Cited by 52
<i>ATM</i> germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignanciesSarah Elitzur, Kjeld Schmiegelow, Ruth Shiloh et al.|Blood|2024Cited by 24